Kodai Capital Management LP Has $28.84 Million Stock Holdings in CME Group Inc. $CME

Key Points

• Kodai Capital Management LP sold 166,099 shares of CME Group Inc., reducing its stake by 60.4%, leaving it with 108,721 shares valued at approximately $28.84 million.
• The recent earnings report for CME Group showed a 12.4% increase in earnings per share year-over-year, with a reported EPS of $2.96 compared to the estimated $2.91.
• CME Group's quarterly dividend of $1.25 per share represents an annualized yield of 1.9%, with an expected dividend payout ratio of 48.4%.

Kodai Capital Management LP cut its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 60.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 108,721 shares of the financial services provider's stock after selling 166,099 shares during the period. Kodai Capital Management LP's holdings in CME Group were worth $28,843,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Wayfinding Financial LLC acquired a new position in shares of CME Group in the first quarter valued at about $25,000. Cornerstone Planning Group LLC grew its stake in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Golden State Wealth Management LLC grew its stake in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Alpine Bank Wealth Management acquired a new position in shares of CME Group in the first quarter valued at about $32,000. Finally, Financial Gravity Asset Management Inc. acquired a new position in shares of CME Group in the first quarter valued at about $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director William R. Shepard purchased 256 shares of the company's stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their position. The disclosure for this purchase can be found here. 0.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on CME shares. Piper Sandler upped their price target on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Barclays set a $298.00 price target on CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Oppenheimer boosted their price target on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Finally, Citigroup boosted their price target on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $261.93.

CME Group Trading Down 0.1%

Shares of CME Group stock traded down $0.26 on Monday, hitting $266.51. The stock had a trading volume of 1,562,708 shares, compared to its average volume of 1,859,420. The stock has a 50 day moving average of $275.64 and a 200 day moving average of $269.50. The firm has a market capitalization of $96.04 billion, a P/E ratio of 25.80, a PEG ratio of 4.82 and a beta of 0.43. CME Group Inc. has a twelve month low of $207.75 and a twelve month high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business earned $2.56 EPS. Sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.